ISIS 5320 inhibitor of the binding of HIV V3 loop to CD4 cells: Phase I Update

Isis Pharmaceuticals (ISIP), Carlsbad, Calif.

Read the full 54 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE